Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|February 25, 2017
Synthesis of Indolines by a Zn-Mediated Mannich Reaction/Pd-Catalyzed Amination SequenceMarc Presset, Antoine Pignon, Jérôme Paul, et al.
Chemmedchem|July 19, 2019
Design and Biological Evaluation of Manganese- and Ruthenium-Based Hybrid CO-RMs (HYCOs)Anthony Ollivier, Roberta Foresti, Zeina El Ali, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Synthesis of 2,3-di- and 2,2,3-trisubstituted-3-methoxycarbonyl-γ-butyrolactones as potent antitumor agentsCamille Le Floch, Erwan Le Gall, Stéphane Sengmany, et al.
Chemosphere|July 29, 2014
Anticipating the fate and impact of organic environmental contaminants: a new approach applied to the pharmaceutical furosemideCéline Laurencé, Michael Rivard, Thierry Martens, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 19, 2005
Liquid chromatography-mass spectrometry assay for quantitation of ifosfamide and its N-deschloroethylated metabolites in rat microsomal mediumThomas Storme, Lionel Mercier, Alain Deroussent, et al.
Faraday Discussions|March 30, 2012
Synthesis of small metallic Mg-based nanoparticles confined in porous carbon materials for hydrogen sorptionClaudia Zlotea, Clotaire Chevalier-César, Eric Léonel, et al.
Journal of Medicinal Chemistry|January 6, 2016
Diverse Nrf2 Activators Coordinated to Cobalt Carbonyls Induce Heme Oxygenase-1 and Release Carbon Monoxide in Vitro and in VivoAniket Nikam, Anthony Ollivier, Michael Rivard, et al.
Redox Biology|November 5, 2018
HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharideRoberto Motterlini, Aniket Nikam, Sylvie Manin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2008
New ifosfamide analogs designed for lower associated neurotoxicity and nephrotoxicity with modified alkylating kinetics leading to enhanced in vitro anticancer activityThomas Storme, Alain Deroussent, Lionel Mercier, et al.
Biochemical Pharmacology|December 12, 2018
A new human pyridinium metabolite of furosemide, inhibitor of mitochondrial complex I, is a candidate inducer of neurodegenerationCéline Laurencé, Narimane Zeghbib, Michael Rivard, et al.
Pageof 3